Head-to-head · Cost-Efficiency Index
CoreAge Rx vs Midi Health
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
CoreAge Rx
Anyone optimizing for real value — a transparent flat price you can model for a full year, nationwide, without a bait-and-switch.
Visit CoreAge RxMidi Health
Cost-first shoppers who want women already managing menopause who want their GLP-1 prescriber on the same platform, with no separate membership fee.
Visit Midi HealthThe verdict
CoreAge Rx takes it, leading the Cost-Efficiency Index 94 to 57. Best value in the ranking: both molecules at one flat, all-50 price with no teaser step-ups — the lowest true cost of ownership, not the lowest teaser. Midi Health still earns a C — Cost-first shoppers who want women already managing menopause who want their GLP-1 prescriber on the same platform, with no separate membership fee.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | CoreAge Rx | Midi Health |
|---|---|---|
| Cost-Efficiency Index | 94/100 | 57/100 |
| Semaglutide / mo | $99/mo | $166/mo (0.5 mg dose, plus a separate fee, compounded) |
| Tirzepatide / mo | $149/mo | $210/mo (2.5 mg dose, plus a separate fee, compounded) |
| Semaglutide / yr (modeled) | $1,188 | $1,992 |
| Tirzepatide / yr (modeled) | $1,788 | $2,520 |
| Coverage | All 50 states | All 50 states |
| Oral / sublingual | No | No |
| Brand-name access | Compounded only | Compounded only |
| Rank here | #1 | #308 |
CoreAge Rx
94/100Where the value is
- Flat all-in monthly price — no intro rate that silently triples after month one, so the modeled annual cost is the real cost
- Both compounded semaglutide and tirzepatide on one account at published prices
- Available in all 50 states — no coverage gamble
The tradeoffs
- Not the rock-bottom sticker price — 30 of the 381 priced semaglutide programs we track list a cheaper figure, though most attach a term or a step-up that CoreAge does not
- No FDA-approved brand-name option (compounded only)
Midi Health
57/100Where the value is
- No membership fee — the site states outright 'You only pay for your care and your medications'
- Medication price already includes shipping and supplies, so the listed number is closer to the true out-of-pocket cost than sites that add fees later
- Dose-tiered pricing is published transparently: compounded semaglutide $165.90-$355.00/mo, compounded tirzepatide $210.00-$434.00/mo depending on dose
The tradeoffs
- The advertised 'Weekly doses start at $34' teaser on the weight-management overview page refers to microdosing, not the standard program — the real 4-week program cost starts at $165.90/mo, over 4x the teaser figure
- Weight care is not Midi's core identity — it's layered onto a menopause/HRT platform, so patients whose only need is GLP-1 may find a weight-loss-only provider more streamlined
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.